Terms: = Colorectal cancer AND CEACAM5, CEA AND Staging
333 results:
1. Elevated serum homocysteine levels associated with poor recurrence-free and overall survival in patients with colorectal cancer.
Xie H; Wei L; Wang Q; Tang S; Gan J
Sci Rep; 2024 May; 14(1):10057. PubMed ID: 38698172
[TBL] [Abstract] [Full Text] [Related]
2. Implications of Pretreatment Serum Carcinoembryonic Antigen Levels and Perineural Invasion with staging, Prognosis, and Management in Stage I-III Colon cancer after Surgery: A Retrospective Cohort Study in the SEER Database.
Zhang Q; Wang L; Sun R; Gao J; Liu T
Ann Ital Chir; 2024; 95(2):144-154. PubMed ID: 38684496
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic and predictive value of tumor deposits in advanced signet ring cell colorectal cancer: SEER database analysis and multicenter validation.
Li F; Liu L; Feng Q; Wang X; Liu F; Yang L; Miao L; Wang W; Ji G; Yu C
World J Surg Oncol; 2024 Apr; 22(1):107. PubMed ID: 38644507
[TBL] [Abstract] [Full Text] [Related]
4. Construction and validation of artificial intelligence pathomics models for predicting pathological staging in colorectal cancer: Using multimodal data and clinical variables.
Tan Y; Liu R; Xue JW; Feng Z
Cancer Med; 2024 Apr; 13(7):e6947. PubMed ID: 38545828
[TBL] [Abstract] [Full Text] [Related]
5. A prediction nomogram for perineural invasion in colorectal cancer patients: a retrospective study.
Que Y; Wu R; Li H; Lu J
BMC Surg; 2024 Mar; 24(1):80. PubMed ID: 38439014
[TBL] [Abstract] [Full Text] [Related]
6. The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: Insights from ypT stage.
Cai Y; Chen M; Ye F; Liu Z; Luo S; Huang L; Kang L
Eur J Surg Oncol; 2024 Apr; 50(4):108001. PubMed ID: 38364330
[TBL] [Abstract] [Full Text] [Related]
7. The clinical value of a nomogram constructed from cea, CA199, PT, FIB, tumor differentiation and TNM stage in colorectal cancer.
Wang K; Ma L; Chen L; Jiang Y; Liu N; Cai J; Zhang Y
Cancer Biomark; 2023; 38(4):537-549. PubMed ID: 37980649
[TBL] [Abstract] [Full Text] [Related]
8. Mesenteric Castleman Disease Misdiagnosed as Lymph Node Metastasis of Rectal cancer on 18 F-FDG PET/CT.
Liu M; Zhou J; Zhu W; Huo L; Cheng W
Clin Nucl Med; 2023 Nov; 48(11):985-986. PubMed ID: 37703486
[TBL] [Abstract] [Full Text] [Related]
9. Value of biplane transrectal ultrasonography plus micro-flow imaging in preoperative T staging and rectal cancer diagnosis in combination with cea/CA199 and MRI.
Xia Q; Cheng W; Bi J; Ren AP; Chen X; Li T
BMC Cancer; 2023 Sep; 23(1):860. PubMed ID: 37700269
[TBL] [Abstract] [Full Text] [Related]
10. A novel risk model for predicting peritoneal metastasis in colorectal cancer based on the SEER database.
Yao L; Shao H; Zhang X; Huang X
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15989-16000. PubMed ID: 37679653
[TBL] [Abstract] [Full Text] [Related]
11. Construction of the survival nomograms for colon cancer patients of different ages based on the SEER database.
Yang Y; Xu P; Zhang C
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15395-15406. PubMed ID: 37639008
[TBL] [Abstract] [Full Text] [Related]
12. Preoperative prognostic nutritional index associated with anastomotic leakage in colorectal cancer patients after surgery.
Wei H; Wang J; Jiang Z; Liu Y; Jiang S; Hu B
Adv Clin Exp Med; 2024 Apr; 33(4):351-359. PubMed ID: 37540157
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic role of metabolic 18F-FDG PET/CT parameters and hematological prognostic indicators in patients with colorectal cancer.
Cengiz A; Yersal Ö; Ömürlü İK; Yürekli Y
Indian J Cancer; 2023; 60(2):224-229. PubMed ID: 37530245
[TBL] [Abstract] [Full Text] [Related]
14. Accuracy of pre-operative 18-fluoride fluorodeoxyglucose positron emission tomography (FDG-PET) in predicting lymph node involvement in colon cancer.
Gauci CM; Kim TJ; Gao Y; Perera DS
ANZ J Surg; 2023 Nov; 93(11):2675-2679. PubMed ID: 37530228
[TBL] [Abstract] [Full Text] [Related]
15. Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of cea-Positive colorectal cancer.
Lwin TM; Minnix M; Li L; Sherman A; Hong T; Wong JYC; Olafsen T; Poku E; Bouvet M; Fong Y; Shively JE; Yazaki PJ
Mol Imaging Biol; 2023 Aug; 25(4):727-734. PubMed ID: 37341873
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of Clinical Diagnostic and Prognostic Value of Preoperative Serum Carcinoembryonic Antigen, CA19-9, and CA24-2 for colorectal cancer.
Hou S; Jing J; Wang Y; Du L; Tian B; Xu X; Sun T; Shi Y
Altern Ther Health Med; 2023 Sep; 29(6):192-197. PubMed ID: 37295009
[TBL] [Abstract] [Full Text] [Related]
17. Development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection.
Zhao B; Wang J; Ma Z; Ye H; Yang T; Meng K
Pathol Oncol Res; 2023; 29():1611014. PubMed ID: 37151355
[No Abstract] [Full Text] [Related]
18. Plasma exosomal protein PLG and SERPINA1 in colorectal cancer diagnosis and coagulation abnormalities.
Li L; Song X; Chen G; Zhang Z; Zheng B; Zhang Q; Wang S; Xie L
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8507-8519. PubMed ID: 37093347
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancer.
Qu A; Wang Q; Chang Q; Liu J; Yang Y; Zhang X; Zhang Y; Zhang X; Wang H; Zhang Y
Sci Rep; 2023 Jan; 13(1):1350. PubMed ID: 36693876
[TBL] [Abstract] [Full Text] [Related]
20. Potential diagnostic role of circulating MiRNAs in colorectal cancer.
Abo-Elela DA; Salem AM; Swellam M; Hegazy MG
Int J Immunopathol Pharmacol; 2023; 37():3946320221144565. PubMed ID: 36598779
[TBL] [Abstract] [Full Text] [Related]
[Next]
